Some physicochemical properties of cathepsin H from human meningioma

Experimental Oncology

Volumn 26, Issue 4, 2004, Pages 278-281

  Chornaya, Valentina ^a   Lyannaya, Olga ^a  

^a OLES HONCHAR DNIPRO NATIONAL UNIVERSITY   (Ukraine)

Author keywords

Brain; Cathepsin H; Kinetic parameters; Meningioma

Indexed keywords

AMMONIUM SULFATE; CATHEPSIN H; CONCANAVALIN A; SEPHADEX; SEPHAROSE;

ARTICLE; BRAIN TISSUE; CHROMATOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME ISOLATION; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME RELEASE; GEL FILTRATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENINGIOMA; MOLECULAR WEIGHT; NEOCORTEX; PH; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; TECHNIQUE; CANCER TISSUE;

AUTOPSY; BIOPSY; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MENINGEAL NEOPLASMS; MENINGIOMA;

EID: 12744278409     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wolters PJ, Chapman HA. Importance of lysosomal cysteine proteases in lung disease. Resp Res 2000; 1: 170-7.
2. Riese RJ, Chapman HA. Cathepsins and compart-mentalization in antigen presentation. Curr Opinion Immunol 2000; 12: 107-13.
3. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumor tissues. Biochem J 1992; 28: 273-8.
4. Sires UI, Schmid TM, Fliszar CJ, Wang ZQ, Gluck SL, Welgus HG. Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin B. J Clin Invest 1995; 95: 2089-95.
5. Lah TT, Buck KM, Honn KV. Degradation of laminin by human tumor cathepsin B. Clin Exp Metastasis 1989; 7: 461-8.
6. Antoniou AN, Blackwood SL, Mazzeo D, Watts C. Control of antigen presentation by a single protease cleavage site. Immunity 2000; 12: 391-8.
7. Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA. Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest 1998; 101: 2351-63.
8. Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N, Schlappack O, Glossl J, Mach L. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 1999; 83: 526-31.
9. Lah TT, Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 1998; 379: 125-30.
10. Cuervo AM, Dice JF. When lysosomes get old. Exp Gerontol 2000; 35: 119-31.
11. Juhg H, Lee EY, Lee SI. Age-related changes in ultrastructural features at cathepsin B- and D-containing neurons in rat cerebral cortex. Brain Res 1999; 844: 43-54.
12. Turk D, Guncar G. Lysosomal cysteine pvoteases (cathepsins): promising drug targets. Acta Cryst 2003; D59: 203-13.
13. Kos J, Schweiger A. Cathepsins and cystatins in extracellular fluids - useful biological markers in cancer. Radiol Oncol 2002; 36: 176-9.
14. Lah TT, Kos J, Blejec A, FrKovic-Georgio S, Golouh R, Vrhovec I, Turk V. The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease. Pathol Oncol Res 1997; 3: 89-98.
15. Barrett AJ, McDonald J. Mammalian proteases: a glossary and bibliography. V.1.: The endopeptidases. London: Academic press, 1980; 213 pp.
16. Tang J, Wong R. Evolution in the structure and function of aspartic proteases. J Cell Biochem 1987; 33: 53-63.
17. Pokrovskiy AA, Tutelyan VA. Lysosomes. Moskow: Nauka, 1976; 382 pp (In Russian).
18. Salama ZB, Bohley P. Studies on some effectors of lysosomal proteinases from rat liver. Acta Biol Med Germ 1977; 36: 1939-44.
19. Kirschke H, Langner J, Riemann S, Wiederanders B, Ansorge S, Bohley P. Lysosomal cysteine proteinases: protein degradation in health and disease. Elsevier, North Holland, 1980; 15-35.
20. Kageshita T, Yoshii A, Kimura T, Maruo K, Ono T, Himeno M, Nishimura Y. Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumors. Arch Dermatol Res 1995; 287: 266-72.
21. Friedrich B, Yung K, Lein M, Turk I, Rudolph B, Hampel G, Schnorr D, Loening SA. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur J Cancer 1999; 35: 138-44.
22. Histologic classification of CNS tumors. WHO: Geneva, 1983.
23. Schwartz WN, Barrett AJ. Human cathepsin H. Biochem J 1980; 191: 487-97.
24. Kochetov GA. Manual on enzymology. Moskow: Vyschaya shkola, 1980; 272 pp (In Russian).
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
26. Lowry OH, Rosenbrough HI, Farr ZA, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
27. Azaryan AV. Peptide hydrolases of nervous system and their biological functions. Erevan: Ajastan, 1989; 207 pp (In Russian).
28. Sivaparvathi M, Sawaya R, Gokaslan Z, Chintala SK, Rao JS, Chintala KS. Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Lett 1996; 104: 121-6.
29. Cornish-Bouden A. Fundamental of enzyme kinetics. London: Portland Press Ltd. 2002; 343 pp.
30. Azaryan A, Galoyan A. Human and bovine brain cathepsin L and cathepsin H: purification, physico-chemical properties, and specificity. Neurochem Res 1987; 12: 207-14.
31. Guinec N, Dalet-Fumeron V, Pagano M. Digestion in vitro of basal membrane, bovine lens capsule, by human liver lysosome cathepsins B, H and L and ascitic fluid tumor cathepsin B from ovarian adenocarcinoma. Pathol Biol (Paris) 1990; 38: 988-1092.
32. Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer. Clin Chim Acta 2000; 291: 113-5.
33. Kos J, Werle B, Lah T, Brunner N. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers 2000; 15: 84-9.
34. Schwartz MK. Tissue cathepsins as tumor markers. Clin Chim Acta 1995; 237: 67-78.